Conditions: Diabetic Neuropathies Neuralgia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 241
Healthy volunteers: no

Brief summary:
To evaluate the efficacy of pregabalin, using a flexible, optimized dose schedule with dose adjustment based on Daily Pain Rating Scale (DPRS), compared to placebo in subjects with peripheral neuropathic pain.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: pregabalin intervention 2: Placebo
Intervention descriptions: intervention 1: 150-600mg/day, BID intervention 2: Placebo

Protocol document: